About Heqet Therapeutics
Heqet Therapeutics is a spin-out company from King’s College London founded in 2022, based on research in cardiac regeneration conducted by Prof. Mauro Giacca. The company is currently advancing its ncRNA-based formulations into preclinical development.
Facts about Heqet Therapeutics
Facts about Heqet Therapeutics
- Founding: 2022
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology
